annb0t
Top 20
Opthea Limited
MELBOURNE, Australia, May 10, 2022 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; NASDAQ:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announces a presentation at the upcoming Retina World Congress 2022, taking place in Fort Lauderdale, Florida from May 12-15, 2022.
Dr. David Boyer, M.D. will present on OPT-302 Combination Therapy in wet AMD, focusing on the Phase 3 program designed to assess...
>>> Read more: Opthea Presentation at The Retina World Congress 2022
MELBOURNE, Australia, May 10, 2022 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; NASDAQ:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announces a presentation at the upcoming Retina World Congress 2022, taking place in Fort Lauderdale, Florida from May 12-15, 2022.
Dr. David Boyer, M.D. will present on OPT-302 Combination Therapy in wet AMD, focusing on the Phase 3 program designed to assess...
>>> Read more: Opthea Presentation at The Retina World Congress 2022
